Nasaruplase | m-entrepreneurship.com

Product Name :
Nasaruplase

Search keywords :
uPA

drugId :
null

Target Vo:
Urokinase plasminogen activator

Target Vo Short Name :
uPA

Moa_Name:
Urokinase plasminogen activator stimulants

First Approval Country :
Japan

First Approval Date Filter:
1992

Origin Company_Name :
Mitsubishi Pharma Corp

Active Company_Name :
Mitsubishi Pharma Corp

Active Indication_Name:
Venous Thrombosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SQSTM1/p62 Antibody (YA062)
Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Mouse IgG H&L
N-Cadherin Antibody: N-Cadherin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 100 kDa, targeting to N-Cadherin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts